Wednesday, July 8, 2026

Drug profile · INN

levocarnitine

levocarnitine (LEVOCARNITINE) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — levocarnitine
US status
approved
Class
Route
INJECTION
Patents
0
Programs
3
Data quality
0.89

Quick answer

levocarnitine (LEVOCARNITINE) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.

Key facts

INN levocarnitine
Brand LEVOCARNITINE
Route INJECTION
Formulation INJECTABLE

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. ALL3024 Phase 2 · Telethon Foundation · Very High-Risk T-Lineage Acute Lymphoblastic Leukemia (ALL)
  2. Levocarnitine Injection Approved · First People's Hospital · Renal Dialysis
  3. L-Carnitine tartrate Unknown · United Therapeutics Europe · Non-Alcoholic Fatty Liver Disease

Frequently asked questions

What is levocarnitine?

levocarnitine (LEVOCARNITINE) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.

What is the brand name for levocarnitine?

LEVOCARNITINE is a marketed brand name for levocarnitine. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of levocarnitine?

levocarnitine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.